Patents by Inventor Klaus Muhlegger
Klaus Muhlegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8013147Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.Type: GrantFiled: March 2, 2005Date of Patent: September 6, 2011Assignee: Roche Molecular Systems, Inc.Inventors: Klaus Muhlegger, Herbert Von Der Eltz
-
Publication number: 20050222056Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.Type: ApplicationFiled: March 2, 2005Publication date: October 6, 2005Inventors: Klaus Muhlegger, Herbert Von Der Eltz
-
Patent number: 6916616Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxy-nucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).Type: GrantFiled: December 19, 2001Date of Patent: July 12, 2005Assignee: Roche Diagnostics GmbHInventors: Hans-Georg Ihlenfeldt, Axel Schmidt, Klaus Muhlegger, Volker Leitenberger
-
Patent number: 6875859Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation.Type: GrantFiled: March 11, 2002Date of Patent: April 5, 2005Assignee: Roche Diagnostics GmbHInventors: Klaus Mühlegger, Herbert Von Der Eltz
-
Patent number: 6498241Abstract: 2′-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.Type: GrantFiled: November 13, 2000Date of Patent: December 24, 2002Assignee: Roche Diagnostics GmbHInventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Mühlegger, Herbert Von Der Eltz
-
Publication number: 20020119534Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxy-nucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).Type: ApplicationFiled: December 19, 2001Publication date: August 29, 2002Inventors: Hans-Georg Ihlenfeldt, Axel Schmidt, Klaus Muhlegger, Volker Leitenberger
-
Publication number: 20020099202Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.Type: ApplicationFiled: March 11, 2002Publication date: July 25, 2002Applicant: Roche Molecular Systems, Inc.Inventors: Klaus Muhlegger, Herbert Von Der Eltz
-
Patent number: 6403786Abstract: The invention concerns compounds of the general formula (I) in which i:he residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.Type: GrantFiled: July 2, 1999Date of Patent: June 11, 2002Assignee: Roche Molecular Systems, Inc.Inventors: Klaus Mühlegger, Herbert Von der Eltz
-
Publication number: 20020004230Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxynucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).Type: ApplicationFiled: November 19, 1999Publication date: January 10, 2002Inventors: HANS-GEORG IHLENFELDT, AXEL SCHMIDT, KLAUS MUHLEGGER, VOLKER LEITENBERGER
-
Patent number: 6320035Abstract: The invention concerns pyrrolo-[3,2-d]pyrimidine, pyrazolo-[4,3-d]pyrimidine and pyrimidine-furanosides i.e. so-called C-nucleosides of the general formulae I-V or appropriate derivatives as well as processes for their production.Type: GrantFiled: October 25, 2000Date of Patent: November 20, 2001Assignee: Roche Diagnostics GmbHInventors: Klaus Mühlegger, Herbert Von Der Eltz, Frank Seela, Helmet Rosemeyer
-
Patent number: 6211158Abstract: The present invention provides desazapurine-nucleoside derivatives of the general formula: wherein X is a nitrogen atom or a methine radical, W is a nitrogen atom or a C—R4 radical, R1, R2, R3 and R4, which can be the same or different, are hydrogen or halogen atoms, hydroxyl or mercapto groups, lower alkyl, lower alkylthio, lower alkoxy, aralkyl, aralkoxy or aryloxy radicals or amino groups optionally substituted once or twice, R5 is a hydrogen atom or a hydroxyl group, R6 and R7 are each hydrogen atoms or one of them is a halogen atom or a cyano or azido group or an amino group optionally substituted once or twice, whereby one of R6 and R7 can also be a hydroxyl group when X is a methine radical and, in addition, R5 and R7 can together also represent a further valency bond between C-2′ and C-3′ and Y is a hydrogen atom or a mono-, di- or tri-phosphate group.Type: GrantFiled: June 26, 1992Date of Patent: April 3, 2001Assignee: Roche Diagnostics GmbHInventors: Frank Seela, Heinz-Peter Muth, Klaus Kaiser, Werner Bourgeois, Klaus Mühlegger, Herbert Von der Eltz, Hans-Georg Batz
-
Patent number: 6184379Abstract: The invention concerns rhodamine derivatives of the general formulae in which Ca-Cd each denote a C atom, and Ca and Cb as well as Cc and Cd are either linked together by a single bond or by a double bond; X1 to X16 denote independently of one another halogen, sulfonic acid, hydrogen or an alkyl residue with 1-20 C atoms in which the alkyl residue can be substituted with one or several halogen or sulfonic acid residues; R1 and R2 are either identical or different and denote either hydrogen, alkyl with 1-20 C atoms, polyoxyhydrocarbyl units, phenyl or phenylalkyl with 1-3 carbon atoms in the alkyl chain in which the alkyl and/or phenyl residues can be substituted by one or several hydroxy, halogen, sulfonic acid, amino, carboxy or alkoxycarbonyl groups where alkoxy can have 1-4 carbon atoms, R1 contains at least one activatable group, R2 and X4 can be optionally linked together via a bridge composed of 0-2 C atoms.Type: GrantFiled: June 2, 1999Date of Patent: February 6, 2001Assignee: Roche Diagnostics GmbHInventors: Hans-Peter Josel, Rupert Herrmann, Dieter Heindl, Klaus Muhlegger, Gregor Sagner, Karl Heinz Drexhage, Jorg Frantzeskos, Jutta Arden-Jacob
-
Patent number: 6147199Abstract: 2'-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.Type: GrantFiled: May 29, 1998Date of Patent: November 14, 2000Assignee: Boehringer MannheimInventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Muhlegger, Herbert Von Der Eltz
-
Patent number: 5902878Abstract: The subject matter of the invention is a modified phosphoramidite process for the synthesis of nucleotide sequences. By use of a modified nucleoside phosphoramidite it is possible to produce nucleotide sequences which have a modified phosphate residue.Type: GrantFiled: September 19, 1997Date of Patent: May 11, 1999Assignee: Boehringer Mannheim GmbHInventors: Heinz-Hartmut Seliger, Sibylle Berner, Klaus Muhlegger, Herbert Von Der Eltz, Hans-Georg Batz
-
Patent number: 5700919Abstract: The subject matter of the invention is a modified phosphoramidite process for the synthesis of nucleotide sequences. By use of a modified nucleoside phosphoramidite it is possible to produce nucleotide sequences which have a modified phosphate residue.Type: GrantFiled: January 10, 1995Date of Patent: December 23, 1997Assignee: Boehringer Mannhiem GmbHInventors: Heinz-Hartmut Seliger, Sibylle Berner, Klaus Muhlegger, Herbert Von der Eltz, Hans-Georg Batz
-
Patent number: 5198537Abstract: The present invention provides digoxigenin derivatives of the formula: ##STR1## wherein n is a whole number of from 1 to 4 and Z is a carboxyl group or a functional derivative derived therefrom. The present invention also provides digoxigenin conjugates of the general formula: ##STR2## wherein the carrier is an immunogenic carrier material, a nucleic acid or a labelled immunocomponent of a labelled digoxigenin immunoconjugate for use in an immunoassay, m is a number from 1 to the number of coupling positions available on the carrier and Y is the group formed by the reaction of the carboxyl function Z of the digoxigenin derivative of general formula (I) with the reacting position of the carrier material. Also described are uses of these conjugates as nucleic acid probes, immunogens, and in immunoassay.Type: GrantFiled: October 25, 1989Date of Patent: March 30, 1993Assignee: Boehringer Mannheim GmbHInventors: Erasmus Huber, Klaus Muhlegger, Herbert von der Eltz, Bruno Zink
-
Patent number: 5035998Abstract: Reagents for the determination of hydrolase comprises compounds of the formula ##STR1## wherein Z is an organic or inorganic acid residue or a sugar residue, A is an organic or inorganic acid residue, and B is an organic acid residue. Each of R.sup.2 and R.sup.5, is hydrogen, halogen or lower alkyl. Each of R.sup.1, R.sup.3, R.sup.4 and R.sup.6, is hydrogen, halogen, cyano, lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl, or carboxamido groups optical substituted once or twice, or a radical of the formula--COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7in which R.sup.7 is hydrogen or lower alkyl and n is a number from 1 to 4. Additionally, R.sup.6 can be sulpho or nitro.Type: GrantFiled: November 13, 1989Date of Patent: July 30, 1991Assignee: Boehringer Mannheim GmbHInventors: Herbert von der Eltz, Hans-Joachim Guder, Klaus Muhlegger
-
Patent number: 4900822Abstract: Reagents for the determination of hydrolase comprises compounds of the formula ##STR1## wherein Z is an organic or inorganic acid residue or a sugar residue, A is an organic or inorganic acid residue, and B is an organic acid residue. Each of R.sup.2 and R.sup.5, is hydrogen, halogen or lower alkyl. Each of R.sup.1, R.sup.3, R.sup.4 and R.sup.6, is hydrogen, halogen, cyano, lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl, or carboxamido groups optional substituted once or twice, or a radical of the formula--COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7in which R.sup.7 is hydrogen or lower alkyl and n is a number from 1 to 4. Additionally, R.sup.6 can be sulpho or nitro.Type: GrantFiled: December 21, 1987Date of Patent: February 13, 1990Assignee: Boehringer Mannheim GmbHInventors: Herbert von der Eltz, Hans-Joachim Guder, Klaus Muhlegger
-
Patent number: 4719097Abstract: The present invention provides phosphates of resorufin derivatives of the general formulae: ##STR1## wherein R.sup.2 and R.sup.5, which can be the same or different, are hydrogen or halogen atoms or lower alkyl radicals, R.sup.1, R.sup.3, R.sup.4 and R.sup.6, which can be the same or different, are hydrogen or halogen atoms, cyano or carboxy groups or lower alkyl, lower alkoxy, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl radicals or carboxamide groups which are optionally mono- or disubstituted or radicals of the general formula --COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7, R.sup.7 being a hydrogen atom or a lower alkyl radical and n being a whole number of from 1 to 4, and wherein R.sup.6 can additionally also be a sulphonyl or nitro group, Y is a nitrogen atom or an N.fwdarw.O group and M and M', which can be the same or different, are hydrogen atoms or alkali metal, alkaline earth metal or ammonium ions.Type: GrantFiled: September 26, 1986Date of Patent: January 12, 1988Assignee: Boehringer Mannheim GmbHInventors: Klaus Muhlegger, Herbert von der Eltz
-
Patent number: 4148994Abstract: Crystalline salts of .beta.-nicotinamide-adenine-dinucleotide (.beta.-NAD), particularly alkali metal salts thereof are prepared in good yield and high quality to provide an analytically useful .beta.-NAD form.Type: GrantFiled: December 27, 1976Date of Patent: April 10, 1979Assignee: Boehringer Mannheim GmbHInventors: Klaus Muhlegger, Gunter Weimann, Michael Nelboeck-Hochstetter